Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

RNA-seq03:21

RNA-seq

11.7K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
11.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

CDK8 remodels the tumor microenvironment and promotes resistance to KRAS<sup>G12D</sup> inhibitors and daraxonrasib in PDAC.

The EMBO journal·2026
Same author

Advancements in extracellular vesicle research.

Extracellular vesicle·2026
Same author

Human extracellular vesicle blueprints.

Nature cell biology·2025
Same author

Engineered exosomes with Kras<sup>G12D</sup> specific siRNA in pancreatic cancer: a phase I study with immunological correlates.

Nature communications·2025
Same author

Targeting NNMT in fibroblasts reawakens T cells and restores antitumor immunity.

Cell research·2025
Same author

Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer.

Nature cell biology·2025

相关实验视频

Updated: Jan 10, 2026

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

3.8K

scPER:一种严格的计算方法,通过总RNA测序来确定瘤中的细胞亚型,与癌症表型保持一致.

Bingrui Li1,2, Xiaobo Zhou2,3, Raghu Kalluri1,4,5,6,7

  • 1Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 27, 2025
PubMed
概括

scPER使用单细胞RNA测序 (scRNA-seq) 参考数据准确估计瘤中的细胞比例. 这种方法可以识别临床相关的细胞群体,并预测免疫疗法反应,推进癌症研究.

关键词:
癌症生物学 癌症生物学解体解体是一种解体.机器学习是机器学习.瘤微环境是一个微环境.

更多相关视频

Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments
03:49

Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments

Published on: October 13, 2023

1.7K
A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
09:34

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

Published on: October 25, 2018

7.0K

相关实验视频

Last Updated: Jan 10, 2026

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

3.8K
Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments
03:49

Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments

Published on: October 13, 2023

1.7K
A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
09:34

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

Published on: October 25, 2018

7.0K

科学领域:

  • 计算生物学是一种计算生物学.
  • 基因组学就是基因组学.
  • 免疫学 免疫学 免疫学

背景情况:

  • 单细胞RNA测序 (scRNA-seq) 提供了关于细胞多样性的见解,但在处理大型患者队列方面面临挑战.
  • 在批量RNA测序 (批量RNA-seq) 数据中识别表型相关的细胞群对于理解瘤微环境至关重要.

研究的目的:

  • 开发一种强大的计算方法,scPER,用scRNA-seq参考数据估计大量RNA-seq样本中的细胞组成.
  • 增强与表型相关的细胞子集群的识别,并预测临床结果,如免疫治疗反应.

主要方法:

  • scPER结合了对抗性自编码器和极端梯度增强,用于细胞比例估计.
  • 它集成了多种scRNA-seq数据集,构建了全面的参考面板,并将生物信号与技术混因素分开.
  • 该方法与已知方法 (如CIBERSORTx,BayesPrism和Scaden) 相比进行了验证.

主要成果:

  • 与现有方法相比,scPER在细胞比例估计方面表现出更高的准确性.
  • 它准确地预测了转移性黑色素瘤的免疫治疗反应,并确定了一种新的T细胞子集群 (FCRL3+,SLAMF7+).
  • 在转移性尿癌中,scPER预测TGFβ介导的CD4原始T细胞的抑制会影响PD-L1阻断的有效性.

结论:

  • scPER提供了一种强大的方法,用于整合scRNA-seq数据,以估计各种瘤类型的细胞比例.
  • 该方法促进了临床相关细胞群和亚型的识别,有助于生物标志物的发现和治疗策略的开发.